Tyrka Audrey R, Wier Lauren M, Price Lawrence H, Rikhye Kobita, Ross Nicole S, Anderson George M, Wilkinson Charles W, Carpenter Linda L
Mood Disorders Research Program and Laboratory for Clinical Neuroscience, Butler Hospital, 345 Blackstone Boulevard., Providence, RI 02906, USA.
Horm Behav. 2008 Apr;53(4):518-25. doi: 10.1016/j.yhbeh.2007.12.004. Epub 2008 Feb 21.
Temperament and personality traits such as neuroticism and behavioral inhibition are prospective predictors of the onset of depression and anxiety disorders. Exposure to stress is also linked to the development of these disorders, and neuroticism and inhibition may confer or reflect sensitivity to stressors. Several lines of research have documented hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in some patients with major depression, as well as in children and non-human primates with inhibited temperaments. The present investigation tested the hypothesis that stress-reactive temperaments would be predictive of plasma adrenocorticotropin (ACTH) and cortisol concentrations in the dexamethasone/corticotropin-releasing hormone (Dex/CRH) test. Sixty adults completed diagnostic interviews and questionnaires assessing the temperament domains of novelty seeking and harm avoidance and symptoms of anxiety and depression. All subjects were free of any current or past Axis I psychiatric disorder. The Dex/CRH test was performed on a separate visit. A repeated-measures general linear model (GLM) showed a main effect of harm avoidance in predicting cortisol concentrations in the test (F(1, 58)=4.86, p<.05). The GLM for novelty seeking and cortisol response also showed a main effect (F(1, 58)=5.28, p<.05). Higher cortisol concentrations were associated with higher levels of harm avoidance and lower levels of novelty seeking. A significant interaction of time with harm avoidance and novelty seeking (F(4, 53)=3.37, p<.05) revealed that participants with both high levels of harm avoidance and low levels of novelty seeking had the highest cortisol responses to the Dex/CRH test. Plasma ACTH concentrations did not differ as a function of temperament. The results indicate that temperament traits linked to sensitivity to negative stimuli are associated with greater cortisol reactivity during the Dex/CRH test. Increased adrenocortical reactivity, which previously has been linked to major depression and anxiety disorders, may contribute to the association between temperament/personality traits and these disorders.
诸如神经质和行为抑制等气质和人格特质是抑郁症和焦虑症发病的前瞻性预测指标。暴露于压力也与这些疾病的发展有关,神经质和抑制可能赋予或反映对应激源的敏感性。多项研究表明,一些重度抑郁症患者以及气质受抑制的儿童和非人类灵长类动物的下丘脑 - 垂体 - 肾上腺(HPA)轴存在功能亢进。本研究检验了以下假设:在地塞米松/促肾上腺皮质激素释放激素(Dex/CRH)试验中,应激反应性气质可预测血浆促肾上腺皮质激素(ACTH)和皮质醇浓度。60名成年人完成了诊断访谈和问卷,评估了寻求新奇和避免伤害的气质领域以及焦虑和抑郁症状。所有受试者目前或过去均无任何轴I精神障碍。Dex/CRH试验在单独的一次就诊时进行。重复测量一般线性模型(GLM)显示,在预测试验中的皮质醇浓度时,避免伤害有主效应(F(1, 58)=4.86, p<.05)。寻求新奇和皮质醇反应的GLM也显示有主效应(F(1, 58)=5.28, p<.05)。较高的皮质醇浓度与较高的避免伤害水平和较低的寻求新奇水平相关。时间与避免伤害和寻求新奇的显著交互作用(F(4, 53)=3.37, p<.05)表明,避免伤害水平高且寻求新奇水平低的参与者对地塞米松/促肾上腺皮质激素释放激素试验的皮质醇反应最高。血浆ACTH浓度没有因气质而有所不同。结果表明,与对负面刺激的敏感性相关的气质特质与地塞米松/促肾上腺皮质激素释放激素试验期间更高的皮质醇反应性有关。肾上腺皮质反应性增加,此前已与重度抑郁症和焦虑症相关,可能导致气质/人格特质与这些疾病之间的关联。